Special Issue "Application of Botulinum Toxin in Clinical Medicine"
Deadline for manuscript submissions: closed (31 March 2021).
Over the past 25 years, botulinum toxin has emerged as an important clinical tool in the management of a diverse array of medical and aesthetic conditions, including spasticity, focal dystonias, chronic migraine headaches, overactive bladder, and facial wrinkles. The common thread underlying all of these conditions is that their symptoms are dependent on heightened efferent drive and excessive neurotransmitter and/ or neuropeptide release from motor or sensory neurons.
However, recent basic/clinical knowledge has been lacking in the clinical use of botulinum toxins diversely, despite many off-label uses for them.
This Special Issue includes the basic knowledge and clinical experiences of off-label use of botulinum toxin injection.
Prof. Dr. Seong Taek Kim
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- botulinum toxin
- off-label use
- movement disorders